United States – Johnson & Johnson (JNJ.N) said on Thursday that the U.S. Food & Drug Administration has approved its device for a type of condition known as arrhythmia, which triggers irregular heartbeat.
Varipulse, an implantable pulsed field ablation system, creates small burns or freezes in the inside of the heart in order to scar tissue and disrupt the electrical signals that cause the cardiovascular’s irregular beats, as reported by Reuters.
A Growing Field in Heart Health
Other players involved in the development of medical devices include Boston Scientific, a global medical technology and manufacturing company that has many products approved as treatments for atrial fibrillation and irregular heartbeat.
For Drug-Resistant, Episodic Conditions
The health regulator has authorized the Johnson & Johnson device for the treatment of drug-resistant paroxysmal atrial fibrillation in which the symptoms are episodal and typically last from a few minutes to hours, as reported by Reuters.